1050 nm Optical Coherence Tomography of Choroidal Melanocytic Lesions

1050 nm Optical Coherence Tomography of Choroidal Melanocytic Lesions - SDOCT & melanomas.

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON33058

Enrollment

Registered

2009-04-27

Start date

2010-04-04

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

melanoma neoplasma tumor

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: - Age >= 18 years. - Informed consent. - Choroidal melanocytic lesion.

Exclusion criteria

Exclusion criteria: - Media opacities preventing imaging. - Use of systemic or dermatological infrared-photosensitive medication.

Design outcomes

Primary

Measure	Time frame
Correlation of conventional diagnostics and 1050 nm OCT imaging.	—

Secondary

Measure	Time frame
- Ophthalmic examination outcome: benign or malignant aspect of lesion. - Presence of lipofuscin indicates malignancy. - Autofluorescence outcome: hyperautofluorescence indicates malignancy . - Ultrasonography: thickness and diameter of the lesion	—

Countries

Netherlands

Outcome results